Translational Paediatric Oncology in the Era of Immunotherapy and Omics

The symposium will focus on different aspects of how advances in immunology, genetics, cell biology and supportive medicine can lead to optimised therapies and improve survival for children with cancer, ranging from novel targeted therapies adapted to molecular profiling to equality in care. Confirmed speakers include Maria Feychting (Karolinska Institutet), Richard Rosenquist Brandell (SciLife, Stockholm), Marcel Kool (German Cancer Research Center, Heidelberg), John Anderson (University College London), David Gisselsson (Lund Universitet) and Ingrid Øra (HOPE, Karolinska University Hospital).

The symposium will focus on different aspects of how advances in immunology, genetics, cell biology and supportive medicine can lead to optimised therapies and improve survival for children with cancer, ranging from novel targeted therapies adapted to molecular profiling to equality in care.

Confirmed speakers include Maria Feychting (Karolinska Institutet), Richard Rosenquist Brandell (SciLife, Stockholm), Marcel Kool (German Cancer Research Center, Heidelberg), John Anderson (University College London), David Gisselsson (Lund Universitet) and Ingrid Øra (HOPE, Karolinska University Hospital).

The symposium is sponsored by Barncancerfonden and will be free of charge. Light lunch will be served to registered attendees, please register no later than April 16 at https://survey.ki.se/Survey/10620